3 Great Penny Stocks To Own In September 2026

The Federal Reserve’s warning that taming inflation could be painful, with higher interest rates and weaker hiring, puts smaller companies under real pressure. Investors are hunting for businesses that already run tight, clean balance sheets instead of relying on cheap money. That is where lower priced, financially disciplined penny stocks come in. This article highlights three such picks from our screener that aim to prioritise financial strength.

The three penny stocks highlighted below are just a starting sample from this idea, and the full screen surfaced 313 more companies with equally financial health focused stories that are not covered here. If you want to move past a handful of examples and systematically identify stronger balance sheets, head straight into the Financially Fit Penny Stocks screener.

NIO (NIO)

Overview: NIO is a Shanghai based automaker that builds smart electric SUVs and sedans and bundles them with charging, battery swap, and service solutions.

Operations: NIO generates CN¥114.1b from smart electric vehicle related activities, all currently sourced from customers in the People's Republic of China.

Market Cap: Market Cap: US$9.2b

NIO fits the Financially Fit Penny Stocks theme through its focus on real, saleable electric vehicles and energy services that can support recurring cash flow rather than purely speculative growth.

"Expansion and densification of NIO's proprietary Power Swap network and charging infrastructure across China's largest cities and highways removes range anxiety and further differentiates NIO from competitors, accelerating EV adoption and increasing recurring services revenue and margin stability."

The key consideration for investors is how one emerging cost and pricing pressure ultimately affects those future margins.

Those margin questions are exactly what the full narrative for NIO unpacks, separating short term pricing pressure from longer term potential as NIO pushes deeper into services and infrastructure.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a Southeast Asian superapp that combines transport, deliveries, and GrabFin digital finance tools aimed at consumers and merchants.

Operations: Grab Holdings generates about US$1.99b from Deliveries, US$1.31b from Mobility, US$430 million from Financial Services, and US$4 million from Others.

Market Cap: US$11.4b

Grab Holdings fits the Financially Fit Penny Stocks idea through GrabFin, where digital lending, payments, and deposit products are built to support healthier economics for everyday spending and small business cash flow inside a broader superapp ecosystem.

"Adjusted EBITDA increased 54% to $168 million, while its corresponding margin expanded from 13.3% to 16.9%."

What happens to that improving profitability profile if one unresolved funding pressure on GrabFin tilts the balance between growth and risk?

If that funding pressure is the real swing factor, the full narrative for Grab Holdings shows how Grab Holdings could keep accelerating without letting risk quietly outrun reward.

Clover Health Investments (CLOV)

Overview: Clover Health Investments runs Medicare Advantage PPO and HMO plans in the United States and supports doctors through its Clover Assistant software platform.

Operations: Clover Health Investments generates about US$2.48b from insurance premiums, all sourced from members in the United States.

Market Cap: US$2.37b

For a Financially Fit Penny Stocks screen built around financial discipline, Clover Health Investments brings something different through its Medicare Advantage focus and a software layer that is designed to improve care quality and cost control rather than just chase headline enrollment growth.

"The company's differentiated technology-driven care model, particularly the Clover Assistant platform, is described as positioning it to benefit from the healthcare industry's accelerated shift toward technology adoption and data-driven, value-based care, supporting lower medical costs and higher medical margins, with implications for both revenue and net margins."

What ultimately matters for investors is how shifting cost and reimbursement pressure shapes those margins once current momentum is tested.

Those reimbursement swings are exactly what the full narrative for Clover Health Investments breaks down, showing where Clover Health Investments could see margin pressure easing, accelerating or quietly stalling.

Curious To Explore Stronger Alternatives?

Fresh ideas move fast. Screeners surface businesses building quiet momentum before prices start flying and the story gets fully caught by the crowd. Act now and get in early.

• Spot cash generative businesses with room to run by scanning the 30 high quality undervalued stocks while it still sits under the radar for now.
• Track capital pouring into electrification, data centers, and chips by reviewing the curated lineup of 88 AI infrastructure stocks before the next breakout leg.
• Front run the robotics shift by combing through 95 robotics and automation stocks where automation leaders and suppliers are still priced as if momentum has not arrived yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com